Cited by 122Alzheimer's disease research and treatmentsRNA and protein synthesis mechanismsDementia and Cognitive Impairment Research

Tau drives translational selectivity by interacting with ribosomal proteins

Open access
Koren, Shon A., Hamm, Matthew J., Meier, Shelby E., Weiss, Blaine E., Nation, Grant K., Chishti, Emad A., Arango, Juan Pablo, Chen, Jing +3 more·2019·Acta Neuropathologica

Abstract

There is a fundamental gap in understanding the consequences of tau-ribosome interactions. Tau oligomers and filaments hinder protein synthesis in vitro, and they associate strongly with ribosomes in vivo. Here, we investigated the consequences of tau interactions with ribosomes in transgenic mice, in cells, and in human brain tissues to identify tau as a direct modulator of ribosomal selectivity. First, we performed microarrays and nascent proteomics to measure changes in protein synthesis. Using regulatable rTg4510 tau transgenic mice, we determined that tau expression differentially shifts both the transcriptome and the nascent proteome, and that the synthesis of ribosomal proteins is reversibly dependent on tau levels. We further extended these results to human brains and found that tau pathologically interacts with ribosomal protein S6 (rpS6 or S6), a crucial regulator of translation. Consequently, protein synthesis under translational control of rpS6 was reduced under tauopathic conditions in Alzheimer's disease brains. Our data establish tau as a driver of RNA translation selectivity. Moreover, since regulation of protein synthesis is critical for learning and memory, aberrant tau-ribosome interactions in disease could explain the linkage between tauopathies and cognitive impairment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-019-01970-9

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • m6A accumulates in the cytoplasm in response to stress.

    “m6A is known to accumulate in the cytoplasm in response to stress, but the function of cytoplasmic m6A remains to be clearly delineated (Meier et al., 2016; Briggs et al., 2017; Koren et al., 2019; Ries et al., 2019; Wolozin and Ivanov, 2019; Fu and Zhuang, 2020).”

    From β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer’s disease (2024) · cites this paper as Koren et al., 2019

    The Results and Discussion passages address tau, ribosomal proteins, and translation in Alzheimer’s disease, not cytoplasmic m6A accumulation. Searches for m6A accumulation under stress and for N6-methyladenosine found no passage in our copy addressing that claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 65 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Koren, S. A., Hamm, M. J., Meier, S. E., Weiss, B. E., Nation, G. K., Chishti, E. A., Arango, J. P., Chen, J., Zhu, H., Blalock, E. M., & Abisambra, J. F.
Affiliations
  • University of Florida (US)
  • University of Kentucky (US)
Corresponding author
Abisambra, Jose F.
Venue
Acta Neuropathologica
Published
2019-02-13
Volume
137
Issue
4
Pages
571-583
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2914428966
Cited by
122
References
65
Citations by year
2026: 13 · 2025: 13 · 2024: 6 · 2023: 17 · 2022: 21 · 2021: 22 · 2020: 26 · 2019: 4
FWCI
12.52
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institute of Neurological Disorders and Stroke (1R01 NS091329-01)
  • National Center on Minority Health and Health Disparities (L32 MD009205-01)
  • National Institutes of Health (1R21 NS093440, R01NS077284, S10RR029127)
  • U.S. Department of Defense (AZ140097)
  • Alzheimer's Association (NIRG-14-322441)
  • National Institute on Aging (P30 AG028383)
  • National Institute of General Medical Sciences (P20 GM103486)
  • National Cancer Institute (NIH/NCI P30CA177558)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
tau protein, ribosome, ribosomal proteins, ribosomal protein S6, translational regulation, protein synthesis, tauopathy, Alzheimer's disease, rTg4510 mice, transcriptome, cognitive impairment
MeSH terms
Alzheimer Disease, Animals, Brain, Humans, Mice, Transgenic, Ribosomal Proteins, Ribosomes, Protein Biosynthesis, tau Proteins, Tauopathies, Mice, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review